The alpha-Synuclein Proteostasis Network and its Translational Applications in Parkinson's disease
Abstract
Parkinsons disease (PD) is debilitating neurodegenerative condition that results in the loss of mobility and muscle control. A neuropathological hallmark of PD is the presence aberrant inclusions, known as Lewy pathology, of which -synuclein (-Syn) is a major component. The accumulation of -Syn is a likely consequence of an age-related impairment of the proteostasis system regulating -Syn. To investigate this phenomenon, we map the proteostasis network (PN) of -Syn in the Substania nigra at the proteomic and transcriptomic levels. We then define a -Syn proteostasis activity score (PAS) that quantifies the activity of the PN in regulating -Syn. We thus obtain a PAS signature indicative of the disease state, as well as the age-of-death in PD patients, and the brain regional vulnerability to -Syn aggregation. We then outline a digital twin of the -Syn PN in the Substantia nigra cells by training a model on single-cell data. This digital twin is applied towards target identification for PD. In addition, we further describe the application of the PN to facilitate drug repurposing. Overall, our study highlights the implication of the -Syn PN in PD and how simulations and measurements of its activity can help efforts in translational research for PD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- FWCI
- 16.88
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dynamic modelling and analysis of autophagy in the clearance of aggregated α-synuclein in Parkinson's disease
Bojie Yang, Zhuoqin Yang, Heng Liu·bioRxiv·Aug 26, 2022
- α-Synuclein Activates the PI3K/AKT Pathway to Drive Lipid Droplets Accumulation: Implications for Parkinson's Disease
Suaad Abd Elhadi, Jenna Congdon-Loeffler, … Ronit Sharon·bioRxiv·Mar 27, 2025
- Blm10/PA200-activated 20S proteasomes promote α-synuclein degradation and bypass proteasome inhibition in Parkinson disease models
Tariq Tammam Ali, Anton Zhornyak, … Gerhard H. Braus·Aging CellPeer-reviewed·May 28, 2026
- Poly(ADP-ribose) induces α-synuclein aggregation in neuronal-like cells andinteracts with phosphorylated α-synuclein in post mortem PD samples
Laura N. Puentes, Zsofia Lengyel‐Zhand, … Robert H. Mach·bioRxiv·Apr 8, 2020
- Can the lack of fibrillar form of alpha-synuclein in Lewy bodies be explained by its catalytic activity?
I. A. Kuznetsov, A. V. Kuznetsov·bioRxiv·May 9, 2021
- WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease
Maxime Teixeira, Razan Sheta, … Abid Oueslati·bioRxiv·Apr 7, 2026